Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection
-
Published:2021-10
Issue:4
Volume:75
Page:829-839
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Matthews Gail V.ORCID, Bhagani Sanjay, Van der Valk MarcORCID, Rockstroh JuergenORCID, Feld Jordan J., Rauch Andri, Thurnheer ChristineORCID, Bruneau Julie, Kim Arthur, Hellard Margaret, Shaw DavidORCID, Gane Ed, Nelson Mark, Ingiliz PatrickORCID, Applegate Tanya L., Grebely JasonORCID, Marks Phillipa, Martinello MarianneORCID, Petoumenos KathyORCID, Dore Gregory J., van der Valk Marc, Hellard Margaret, Gane Ed, Rauch Andri, Bruneau Julie, Kim Arthur, Bhagani Sanjay, Dore Greg, Marks Pip, Matthews Gail, Grebely Jason, Petoumenos Kathy, Martinello Marianne, Applegate Tanya, Feld Jordan, Rockstroh Jürgen, Matthews Gail, Marks Pip, Amjad Sophia, Tu Elise, Petoumenos Kathy, Tamaddoni Mahshid, van der Valk Marc, Hellard Margaret, Gane Ed, Thurnheer Maria Christine, Gilleece Yvonne, Bruneau Julie, Nelson Mark, Fraser Chris, Moriggia Alberto, Lutz Thomas, Moon Juhi, Read Phillip, Kim Arthur Y., Ustianowski Andrew, Cordes Christiane, Shaw David, Bhagani Sanjay, Sasadeusz Joe, Hull Mark, Dore Greg, Feld Jordan, Rockstroh Jürgen, Braun Dominique, Ingiliz Patrick
Funder
AbbVie Pfizer Janssen Pharmaceuticals Roche Australian Government National Institutes of Health Department of Health and Ageing, Australian Government National Institute on Drug Abuse Gilead Sciences
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|